Skip to content

Weight Fluctuation After Breast Cancer Treatment

Weight Fluctuation After Breast Cancer Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00991653
Enrollment
250
Registered
2009-10-08
Start date
2008-08-31
Completion date
Unknown
Last updated
2018-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Weight Gain

Keywords

Weight, Breast, Cancer

Brief summary

This study aims to identify and quantify the factors associated with excess weight gain following treatment for breast cancer. It is believed that breast cancer patients gain more than 4% of their weight at diagnosis which is likely accompanied by an increase in body fat and waist circumference. It is further thought that this excess weight and increase in body fat and waist circumference are associated to tumour characteristics, chemotherapy, menopause status at diagnosis and the presence of genes related to obesity. It is also thought that women treated with chemotherapy have higher levels of glucose and insulin.

Interventions

PROCEDUREFasting blood sample.

Fasting blood sample taken following informed consent for genotyping, glucose and insulin levels.

Sponsors

The Royal Bournemouth Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Females 18 years of age or older. * Diagnosed with breast cancer between 1/1/2003 and 31/12/2007. * Able to understand and willing to sign informed consent.

Exclusion criteria

* Known diagnosis of previous breast/other cancer (other than completely resected non-melanoma skin cancer or successfully treated in situ cancer of the cervix. * Known diagnosis of inflammatory bowel disease or malabsorption syndrome. * Known diagnosis of endocrine problems associated with the development of obesity (cushings syndrome, hypo/hyperthyroid, thyroiditis) * Treatment for psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
To provide evidence of the relationship between weight gain following diagnosis of breast cancer and tumour characteristics, chemotherapy, menopause status at diagnosis and the presence of genes related to obesity.12-18 months.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026